EUVIMEDEUVIMED entdecken
Crossref

Adverse Events and Device Failures Associated with Pancreatic Stents: A Comprehensive Analysis Using the FDA’s MAUDE Database

Fouad Jaber, Saqr Alsakarneh, Tala Alsharaeh, Ahmed-Jordan Salahat, Mohammad Jaber, Yazan Abboud, Mohammad Aldiabat, Khalid Ahmed, Mohamed Abdallah, Ala Abdel-Jalil, Mohammad Bilal, Monique Barakat und 1 weitere

Digestive Diseases and Sciences · 2024

DOI: 10.1007/s10620-024-08396-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Fouad Jaber und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Stents, Databases, Factual, Pancreatic Ducts. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Pancreatic duct stents (PDS) are widely used for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. However, there is a paucity of data regarding the adverse events associated with PDS placement. This study aims to investigate the reported adverse events and device failures related to PDS, utilizing the Manufacturer and User Facility Device Experience (MAUDE) database maintained by the U.S. Food and Drug Administration (FDA). METHODS: Post-marketing surveillance data from January 2013 to December 8, 2023, were extracted from the FDA's MAUDE database to analyze the reports pertaining to the use of commonly used PDS. The primary outcomes of interest were device issues and patient-related adverse events. Statistical analysis was performed using Microsoft Excel 2010, with the calculation of pooled numbers and percentages for each device and patient adverse event. RESULTS: A total of 579 device issues and 194 patient-related adverse events were identified. Device issues were primarily attributed to stent deformation (n = 72; 12.4%), followed by migration of the device into the pancreatic duct or expulsion out of the duct (n = 60; 10.4%), and stent fracture/breakage (n = 55; 9.4%). Among the patient-reported adverse events, inflammation was the most common (n = 26; 13.4%), followed by reports of stents becoming embedded in tissue (n = 21; 10.8%) and stent occlusion/obstruction (n = 16; 8.2%). The most prevalent device failures associated with Advanix stents were material deformation, with perforation (n = 3, 30%) being the most frequently reported adverse event. Concerning Geenen stents, migration or expulsion of the device (n = 34, 16.9%) constituted the most common device-related adverse events, while inflammation (n = 20, 16.7%) was the most frequently reported patient-related issue. For Zimmon stents, migration or expulsion of the device (n = 22, 8.8%) were the most frequently reported device-related problems, whereas perforation (n = 7, 10.9%) and bleeding (n = 7, 10.9%) were the most frequent patient-related adverse events. CONCLUSION: Our findings highlight important device and patient adverse events that endoscopists and referring providers should be aware of before considering pancreatic stent placement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationStentsDatabases, FactualPancreatic DuctsProduct Surveillance, PostmarketingProsthesis FailureHumansUnited StatesCholangiopancreatography, Endoscopic RetrogradePancreatitisEquipment FailureForeign-Body Migration

Stichwörter der Autor:innen

Adverse eventsFDA MAUDE databasePancreatic duct stentsPost-market surveillance

Autor:innen und Institutionen

  • Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Department of Medical Education, Faculty of Medicine, The University of Jordan, Amman, Jordan.
  • Department of Medical Education, Faculty of Medicine, Al-Azhar University, Gaza, Palestine.
  • Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.

Zitieren

APA

Jaber, F., Alsakarneh, S., Alsharaeh, T., Salahat, A. J., Jaber, M., Abboud, Y., Aldiabat, M., Ahmed, K., Abdallah, M., Abdel-Jalil, A., Bilal, M., Barakat, M., & Adler, D. G. (2024). Adverse Events and Device Failures Associated with Pancreatic Stents: A Comprehensive Analysis Using the FDA’s MAUDE Database. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08396-8

Vancouver

Jaber F, Alsakarneh S, Alsharaeh T, Salahat AJ, Jaber M, Abboud Y, et al. Adverse Events and Device Failures Associated with Pancreatic Stents: A Comprehensive Analysis Using the FDA’s MAUDE Database. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08396-8

BibTeX
@article{Jaber2024,
  author = {Jaber, Fouad and Alsakarneh, Saqr and Alsharaeh, Tala and Salahat, Ahmed-Jordan and Jaber, Mohammad and Abboud, Yazan and Aldiabat, Mohammad and Ahmed, Khalid and Abdallah, Mohamed and Abdel-Jalil, Ala and Bilal, Mohammad and Barakat, Monique and Adler, Douglas G},
  title = {Adverse Events and Device Failures Associated with Pancreatic Stents: A Comprehensive Analysis Using the FDA’s MAUDE Database},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  doi = {10.1007/s10620-024-08396-8}
}
Kostenlos starten →